期刊文献+

细胞角蛋白18片段和炎症相关因子在非酒精性脂肪性肝病不同代谢组分的表达水平及意义 被引量:2

Expression of Cytokeratin 18 fragment and inflammation related factors in nonalcoholic fatty liver disease with different metabolic syndrome compositions
下载PDF
导出
摘要 目的探讨细胞角蛋白18片段、炎症相关因子与代谢综合征(metabolic syndrome,MS)组分多少在非酒精性脂肪性肝病患者(non-alcoholic fatty liver disease,NAFLD)表达水平的差异及其临床意义。方法纳入非酒精性脂肪性肝病患者85例。根据含代谢危险因素1个、2个及3个或以上分为MS1、MS2和MS3 3组。记录入选患者病史和人体学资料,检测生化常规、空腹和餐后2 h血糖和胰岛素、血脂、超敏C反应蛋白、糖化血红蛋白;采用酶联免疫吸附法(ELISA)检测血清中细胞角蛋白18片段、炎症相关因子TNF-α、IL-6表达水平。速率散射比浊法检测血清超敏C-反应蛋白表达水平。结果血清细胞角蛋白18(M30)在MS3组表达与MS1、MS2组比较差异有统计学意义(F=3.77,P<0.05)。IL-6在MS3组中表达水平与MS1、MS2组比较差异有统计学意义(F=6.39,P<0.05)。且ALT、GGT在MS3组中表达水平与MS1组比较差异有统计学意义(F=14.02,P<0.05;F=6.18,P<0.05)。结论非酒精性脂肪性肝病中当代谢危险因素数量达到3个或以上时,反映肝脏凋亡及炎症的细胞角蛋白18片段和炎症相关因子的表达水平较3个以下代谢危险因素者增高,提示代谢危险因素的增多可能是NAFLD病人肝脏凋亡和炎症的危险因素。 Objective To investigate the expression and clinical significance of Cytokeratin 18(CK-18) fragment and inflammation related factors in nonalcoholic fatty liver disease(NAFLD) with different metabolic syndrome(MS) compositions.Methods Eighty-five cases of NAFLD patients were enrolled.All patients were divided into three groups according to the amount of the compositions of MS: MS1,MS2 and MS3.Medical history,physical examination were recorded.The conventional biochemical tests,fasting blood sugar and insulin,postprandial 2 hour sugar,blood lipid,Hs-CRP and glycosylated hemoglobin were performed respectively,serum expression of CK-18 and inflammation related factors TNF-α,IL-6 were measured by ELISA,Hs-CRP was measured by the rate of scattering method.Results there was a significant difference of serum expression of CK-18 fragment in MS3 group,compared with MS1,MS2 groups(P0.05),and the levels of serum IL-6,plasma ALT and GGT in the MS3 group were significantly higher than those in the MS2 and MS1 groups(F=6.39,P0.05;F=14.02,P0.05;F=6.18,P0.05).Conclusion When the compositions of MS are more than or equate to three,the inflammatory reaction and apoptosis of hepatocyte may be more obvious than that less than three compositions.
作者 李良平 钟黄
出处 《胃肠病学和肝病学杂志》 CAS 2011年第7期606-609,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 非酒精性脂肪性肝病 非酒精性脂肪性肝炎 代谢综合征 炎症相关因子 细胞角蛋白18 Nonalcoholic fatty liver disease Nonalcoholic steatohepatitis Metabolic syndrome Inflammation related factors Cytokeratin-18
  • 相关文献

参考文献16

  • 1Feldstein AE, Canbay A, Angulo P, et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis [ J ]. Gastroenterology, 2003, 125 (2) : 437-443.
  • 2Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1513
  • 3杨文英.重视预防,规范管理——2007年版《中国2型糖尿病防治指南》[J].中华内分泌代谢杂志,2008,24(2):121-122. 被引量:121
  • 4钟黄,李良平,韩盛玺.非酒精性脂肪肝、隐源性肝硬化与原发性肝癌发生的关系[J].国际消化病杂志,2009,29(6):402-405. 被引量:11
  • 5Almeda-Vald6s P, Cuevas-Ramos D, Aguilar-Salinas CA, et al. Metabolic syndrome and non-alcoholic fatty liver disease [ J]. Ann Hepatol, 2009, 8(Suppl 1): S18-S24.
  • 6Ganne-Carrie N, Ziol M, Ledinghen VD, et al. Accuracy of liver stillness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases [J]. Hepatology, 2006, 44(6): 1511-1517.
  • 7Tsochatzis E, Papatheodoridis GV, Manesis EK, et al. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis [ J]. Aliment Pharmacol Ther, 2008, 27 (1): 80-89.
  • 8Bugianesi E, Vanni E, Marchesini G. NASH and the risk of cirrhosisAnd hepatocellular carcinoma in type 2 diabetes [J]. Curr Diab Rep, 2007, 7(3) : 175-180.
  • 9Manco M, Marcellini M, DeVito R, et al. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis [ J]. Int J Obes (Lond) , 2008, 32(2): 381-387.
  • 10Bantel H, Lugering A, Heidemann J, et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury [ J]. Hepatology, 2004, 40 (5) : 1078-1087.

二级参考文献28

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2Yusuf Yilmaz,Enver Dolar,Engin Ulukaya,Semra Akgoz,Murat Keskin,Murat Kiyici,Sibel Aker,Arzu Yilmaztepe,Selim Gurel,Macit Gulten,Selim Giray Nak.Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis[J].World Journal of Gastroenterology,2007,13(6):837-844. 被引量:20
  • 3International Diabetes Federation. Diabetes Arias, Second edition. 2003.
  • 4International Diabetes Federation. Diabetes Arias, Third edition. 2007.
  • 5中华人民共和国卫生部.2007中国卫生统计纪要.
  • 6Nathan DM, Cleary PA, Backlund JY, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med, 2005,353:2643-2653.
  • 7Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes ( UKPDS 35 ) : prospective observational study. BMJ, 2000,321:405- 412.
  • 8Gaede P, Vedel P, Larsen N, et al. Muhifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med, 2003,348:383-393.
  • 9Schwimmer JB,Behling C,Newbury R,et al.Histopathology of pediatric nonalcoholic fatty liver disease.Hepatology,2005,42:641-649.
  • 10Neuschwander Tetri BA,Caldwell SH.Nonalcoholic steatohepatitis:summary of an AASLD Single Topic Conference.Hepatology,2003,37:1202-1219.

共引文献1641

同被引文献22

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部